Scientists have created a new blood test capable of diagnosing 70 early stage, solid tumour cancers.
The TruCheck Intelli cancer blood test, which is now available in the UK, works by detecting circulating tumour cells (CTCs) in the blood.
Clinical trials of over 40,000 participants have found the test has a sensitivity of 88.2 per cent, which is its ability to detect CTCs in blood samples from cancer cases. The test is 96.8 per cent accurate.
Early identification of tumours is key in the treatment of cancer and increases the chance of remission. ES.
.jpeg)